Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.

Chan LC, Li CW, Xia W, Hsu JM, Lee HH, Cha JH, Wang HL, Yang WH, Yen EY, Chang WC, Zha Z, Lim SO, Lai YJ, Liu C, Liu J, Dong Q, Yang Y, Sun L, Wei Y, Nie L, Hsu JL, Li H, Ye Q, Hassan MM, Amin HM, Kaseb AO, Lin X, Wang SC, Hung MC.

J Clin Invest. 2019 Jul 15;130. pii: 126022. doi: 10.1172/JCI126022. eCollection 2019 Jul 15.

2.

Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study.

Habra MA, Sukkari MA, Hasan A, Albousen Y, Elsheshtawi MA, Jimenez C, Campbell M, Karam JA, Graham PH, Hatia RI, Phan AT, Varghese J, Hassan MM.

Int J Cancer. 2019 Jun 26. doi: 10.1002/ijc.32534. [Epub ahead of print]

PMID:
31241762
3.

Vitamin C and Vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study.

Li D, Tang H, Wei P, Zheng J, Daniel CR, Hassan MM.

J Nutr. 2019 May 17. pii: nxz081. doi: 10.1093/jn/nxz081. [Epub ahead of print]

PMID:
31100111
4.

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma.

Pestana RC, Hassan MM, Abdel-Wahab R, Abugabal YI, Girard LM, Li D, Chang P, Raghav K, Morris J, Wolff RA, Rashid A, Amin HM, Kaseb A.

Oncotarget. 2018 Dec 28;9(102):37721-37732. doi: 10.18632/oncotarget.26507. eCollection 2018 Dec 28.

5.

Dietary N-nitroso compounds and risk of pancreatic cancer: results from a large case-control study.

Zheng J, Stuff J, Tang H, Hassan MM, Daniel CR, Li D.

Carcinogenesis. 2019 Apr 29;40(2):254-262. doi: 10.1093/carcin/bgy169.

PMID:
30475991
6.

Genetic landscape of gallbladder cancer: Global overview.

Mehrotra R, Tulsyan S, Hussain S, Mittal B, Singh Saluja S, Singh S, Tanwar P, Khan A, Javle M, Hassan MM, Pant S, De Aretxabala X, Sirohi B, Rajaraman P, Kaur T, Rath GK.

Mutat Res. 2018 Oct - Dec;778:61-71. doi: 10.1016/j.mrrev.2018.08.003. Epub 2018 Aug 23. Review.

PMID:
30454684
7.

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.

Al Omari A, Abdelkhaleq H, Al-Hussaini M, Turfa R, Awad N, Hassan MM, Alfaqih MA, Garrett CR.

J Glob Oncol. 2018 Jul;4:1-10. doi: 10.1200/JGO.18.00018.

8.

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma.

Niekamp A, Abdel-Wahab R, Kuban J, Odisio BC, Mahvash A, Hassan MM, Qayyum A, Kaseb A, Sheth RA.

J Clin Med. 2018 Apr 14;7(4). pii: E83. doi: 10.3390/jcm7040083.

9.

Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.

Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO.

Oncology. 2017;93(4):233-242. doi: 10.1159/000455957. Epub 2017 Jul 6.

PMID:
28683459
10.

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.

Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1791-1799. doi: 10.1016/j.cgh.2017.05.036. Epub 2017 Jun 1.

11.

Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.

Al-Shamsi HO, Jones J, Fahmawi Y, Dahbour I, Tabash A, Abdel-Wahab R, Abousamra AO, Shaw KR, Xiao L, Hassan MM, Kipp BR, Kopetz S, Soliman AS, McWilliams RR, Wolff RA.

J Gastrointest Oncol. 2016 Dec;7(6):882-902. doi: 10.21037/jgo.2016.11.02.

12.

Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.

Takeuchi S, Rohren EM, Abdel-Wahab R, Xiao L, Morris JS, Macapinlac HA, Hassan MM, Kaseb AO.

Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):969-978. doi: 10.1007/s00259-016-3583-2. Epub 2016 Dec 12.

13.

Serum exosomal miR-4772-3p is a predictor of tumor recurrence in stage II and III colon cancer.

Liu C, Eng C, Shen J, Lu Y, Takata Y, Mehdizadeh A, Chang GJ, Rodriguez-Bigas MA, Li Y, Chang P, Mao Y, Hassan MM, Wang F, Li D.

Oncotarget. 2016 Nov 15;7(46):76250-76260. doi: 10.18632/oncotarget.12841.

14.

Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.

Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS.

J Gastrointest Surg. 2016 Oct;20(10):1725-31. doi: 10.1007/s11605-016-3216-x. Epub 2016 Jul 25.

PMID:
27456016
15.

Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer.

Li D, Mao Y, Chang P, Liu C, Hassan MM, Yeung SJ, Abbruzzese JL.

Am J Cancer Res. 2015 Sep 15;5(10):3260-9. eCollection 2015.

16.

Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma.

Sohn BH, Shim JJ, Kim SB, Jang KY, Kim SM, Kim JH, Hwang JE, Jang HJ, Lee HS, Kim SC, Jeong W, Kim SS, Park ES, Heo J, Kim YJ, Kim DG, Leem SH, Kaseb A, Hassan MM, Cha M, Chu IS, Johnson RL, Park YY, Lee JS.

Clin Cancer Res. 2016 Mar 1;22(5):1256-64. doi: 10.1158/1078-0432.CCR-15-1447. Epub 2015 Oct 12.

17.

Reply: To PMID 25836985.

Hassan MM, Abdel-Wahab R, Li D, Kaseb AO.

Gastroenterology. 2015 Nov;149(6):1643-4. doi: 10.1053/j.gastro.2015.09.035. Epub 2015 Oct 1. No abstract available.

PMID:
26433110
18.

Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma.

Abdel-Wahab R, Shehata S, Hassan MM, Xiao L, Lee JS, Cheung S, Essa HH, Hassabo HM, Shalaby AS, Mosad E, Raghav K, Rashid A, Wolff RA, Morris JS, Amin HM, Kaseb AO.

Oncotarget. 2015 Aug 28;6(25):21193-207.

19.

Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.

Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D.

Gastroenterology. 2015 Jul;149(1):119-29. doi: 10.1053/j.gastro.2015.03.044. Epub 2015 Mar 30.

20.

Hepatocellular carcinoma as a second primary cancer in patients with chronic hepatitis C virus infection.

Mahale P, Kaseb AO, Hassan MM, Torres HA.

Dig Liver Dis. 2015 Apr;47(4):348-9. doi: 10.1016/j.dld.2014.12.005. Epub 2014 Dec 17. No abstract available.

PMID:
25563811

Supplemental Content

Loading ...
Support Center